Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 16.36% is 692% above its 5-year average of -2.76%, near the high end of its 5-year range (-21.45%–18.62%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.83% above its 12-month average of 13.21%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 16.36%.
RETURN ON EQUITY (ROE)
16.36%
RETURN ON EQUITY (ROE) AVG TTM
13.21%
RETURN ON EQUITY (ROE) AVG 3Y
5.37%
RETURN ON EQUITY (ROE) AVG 5Y
-2.76%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+23.83%
CURRENT VS 3Y AVG
+204.62%
CURRENT VS 5Y AVG
+691.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 96 covered companies
CURRENT VS SECTOR MEDIAN
+42.98%
vs the sector median at left
Inspire Medical Systems, Inc.
Market Cap
$2.02B
Return on Equity (ROE)
16.36%
TTM Avg
13.21%
3Y Avg
5.37%
5Y Avg
-2.76%
Market Cap
$1.90B
Return on Equity (ROE)
-16.25%
TTM Avg
-99.56%
3Y Avg
-48.75%
5Y Avg
-32.00%
Market Cap
$2.16B
Return on Equity (ROE)
-56.71%
TTM Avg
-50.91%
3Y Avg
-55.48%
5Y Avg
-35.68%
Market Cap
$1.74B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
Market Cap
$1.71B
Return on Equity (ROE)
-54.96%
TTM Avg
-60.50%
3Y Avg
-51.30%
5Y Avg
-42.73%
Market Cap
$2.52B
Return on Equity (ROE)
-8.00%
TTM Avg
-28.91%
3Y Avg
-27.68%
5Y Avg
-39.13%
Market Cap
$2.76B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$1.00B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$474.59M
Return on Equity (ROE)
-6.60%
TTM Avg
-10.82%
3Y Avg
-11.36%
5Y Avg
-7.59%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | $2.02B | 16.36% | 13.21% | 5.37% | -2.76% |
| Fortrea Holdings Inc. (FTRE)vs › | $1.90B | -16.25% | -99.56% | -48.75% | -32.00% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -56.71% | -50.91% | -55.48% | -35.68% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | -40.41% | -45.75% | -30.11% | -18.95% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -54.96% | -60.50% | -51.30% | -42.73% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -8.00% | -28.91% | -27.68% | -39.13% |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 29.28% | 27.86% | 4.54% | -12.45% |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -13.54% | -40.81% | -170.75% | -114.78% |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | -6.60% | -10.82% | -11.36% | -7.59% |
| NRC Health (NRC)vs › | $458.62M | 89.43% | 81.07% | 67.39% | 61.90% |
ROE
16.4%
ROA
14.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 16.36% |
| 2026-03-31 | 16.55% |
| 2025-12-31 | 18.62% |
| 2025-09-30 | 6.69% |
| 2025-06-30 | 7.84% |
| 2025-03-31 | 10.46% |
| 2024-12-31 | 7.76% |
| 2024-09-30 | 4.74% |
| 2024-06-30 | 0.94% |
| 2024-03-31 | -2.67% |
| 2023-12-31 | -3.69% |
| 2023-09-30 | -6.02% |
| 2023-06-30 | -7.76% |
| 2023-03-31 | -8.64% |
| 2022-12-31 | -9.05% |
| 2022-09-30 | -10.72% |
| 2022-06-30 | -19.35% |
| 2022-03-31 | -18.89% |
| 2021-12-31 | -18.36% |
| 2021-09-30 | -21.40% |
| 2021-06-30 | -21.45% |
| 2021-03-31 | -25.62% |
| 2020-12-31 | -24.90% |
| 2020-09-30 | -25.70% |
| 2020-06-30 | -24.26% |
| 2020-03-31 | -32.36% |
| 2019-12-31 | -23.77% |
| 2019-09-30 | -19.82% |
| 2019-06-30 | -16.65% |
| 2019-03-31 | -14.99% |
| 2018-12-31 | -13.31% |
| 2018-09-30 | -21.67% |
| 2018-06-30 | -20.11% |
